ExLibris header image
SFX Logo
Title: A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis
Source:

Nature Genetics [1061-4036] Helms, Cynthia yr:2003


Collapse list of basic services Basic
Full text
Full text available via Nature
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Medzhitov, R. "Decoding the Patterns of Self and Nonself by the Innate Immune System." Science 296.5566 (2002): 298-300. Link to SFX for this item
2. Look, A T T. "Oncogenic transcription factors in the human acute leukemias." Science 278.5340 (1997): 1059-64. Link to SFX for this item
3. Hruby, Victor J J. "Heterobivalent ligands crosslink multiple cell-surface receptors: the human melanocortin-4 and delta-opioid receptors." Angewandte Chemie (International ed.) 47.9 (2008): 1685-8. Link to Full Text for this item Link to SFX for this item
4. Medzhitov, Charles A A. "Innate immune recognition." Annual review of immunology 20.1 (2002): 197-216. Link to Full Text for this item Link to SFX for this item
5. Medzhitov, R. "Innate immune recognition: mechanisms and pathways." Immunological reviews 173.1 (2000): 89-97. Link to Full Text for this item Link to SFX for this item
6. Raitano, A. "Signal transduction by wild-type and leukemogenic Abl proteins." Biochimica et biophysica acta. Reviews on cancer 1333.3 (1997). Link to Full Text for this item Link to SFX for this item
7. MEDZHITOV, R. "Innate immunity." New England Journal of Medicine, The 343.5 (2000): 338-44. Link to SFX for this item
8. Takeuchi, O. "Pathogen recognition and innate immunity." Cell 124.4 (2006): 783-801. Link to SFX for this item
9. Schuresko, Laura A. "A practical solid-phase synthesis of Glu7-phalloidin and entry into fluorescent F-actin-binding reagents." Angewandte Chemie (International ed.) 46.19 (2007): 3547-3549. Link to Full Text for this item Link to SFX for this item
10. Slack, J L L. "The biology and treatment of acute progranulocytic leukemia." Current opinion in oncology 11.1 (1998): 9-13. Link to SFX for this item
11. Pui, A Thomas T. "Acute lymphoblastic leukaemia." Lancet, The 371.9617 (2008): 1030-43. Link to SFX for this item
12. Brent, L. "Crystal-ball gazing - The future of immunological research viewed from the cutting edge." Clinical and experimental immunology 147.1 (2007): 1-10. Link to Full Text for this item Link to SFX for this item
13. Nucifora, G. "Persistence of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long-term remission." Blood 82.3 (1993): 712-5. Link to SFX for this item
14. Hanahan, D. "The hallmarks of cancer." Cell 100.1 (1999): 57-70. Link to SFX for this item
15. Rosca, E. "Specificity and mobility of biomacromolecular, multivalent constructs for cellular targeting." Biomacromolecules 8.12 (2007): 3830-3835. Link to Full Text for this item Link to SFX for this item
16. Weinberg, Robert A. "Hallmarks of cancer: the next generation." Cell 144.5 (2011): 646-674. Link to SFX for this item
17. Takeda, K. "Toll-like receptors." Annual review of immunology 21.1 (2003): 335-76. Link to Full Text for this item Link to SFX for this item
18. Medzhitov, R. "Toll-like receptor control of the adaptive immune responses." Nature immunology 5.10: 987-995. Link to SFX for this item
19. Lazebnik, Y. "What are the hallmarks of cancer?" Nature Reviews. Cancer 10.4 (2010): 232-3. Link to SFX for this item
20. Kawai, S. "Innate immune recognition of viral infection." Nature immunology 7.2 (2006): 131-7. Link to Full Text for this item Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced